Valproic acid-induced Hyperammonemic Encephalopathy
- 1 January 2020
- journal article
- letter
- Published by Kare Publishing in Dusunen Adam the Journal of Psychiatry and Neurological Sciences
- Vol. 33 (2), 218-220
- https://doi.org/10.14744/dajpns.2020.00083
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Changing incidence of hyperammonemia in Japan from 2006 to 2013: expansion of new antiepileptic drugs reduces the risk of hyperammonemiaEuropean Journal of Clinical Pharmacology, 2015
- Risk Factors of Hyperammonemia in Patients With Epilepsy Under Valproic Acid TherapyMedicine, 2014
- Valproic acid induced hyperammonaemic encephalopathy: case reportJournal of Mood Disorders, 2014
- Risperidone, a risk factor for valproate-induced encephalopathy?General Hospital Psychiatry, 2013
- Valproic Acid and Topiramate Induced Hyperammonemic Encephalopathy in a Patient With Normal Serum CarnitineThe Journal of Pediatric Pharmacology and Therapeutics, 2013
- Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and managementGeneral Hospital Psychiatry, 2012
- Valproate-induced hyperammonemic encephalopathy: a brief reviewCurrent Medical Research and Opinion, 2012
- Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathyActa Neurologica Scandinavica, 2007
- Valproate-induced hyperammonemic encephalopathyActa Neurologica Scandinavica, 2006
- Acute Valproate PoisoningJournal of Clinical Psychopharmacology, 2005